Markwell Clarizio LLP

Team Members

Jason Markwell

Jason Markwell*

Jason is a leading patent and drug regulatary litigation lawyer in Canada. Jason draws on twenty-five years of experience in global and national law firms to provide clients with practical advice to meet their commercial goals.
Jason has appeared as counsel in precedent-setting cases before the Supreme Court of Canada, the Federal Court of Appeal, the Federal Court, the Ontario Superior Court of Justice, and the Patented Medicine Prices Review Board.
Jason has been recognized as a leading lawyer in many legal publications, including Chambers & Partners, IAM Patent 1000, The Best Lawyers Canada, Who’s Who Legal, IP Stars, Martindale Hubbell, Lexpert (consistently recommended in Intellectual Property, Litigation-Intellectual Property, and Life Sciences), Benchmark Litigation (IP Litigator of the Year, 2017), The Lexpert/American Lawyer Guide to the Leading 500 Lawyers in Canada, Managing Intellectual Property (Outstanding IP Practitioner – Canada, 2019), and LMG Life Sciences (Lawyer of the Year, 2018, Patent Litigation). Jason is active in various intellectual property organizations, including the Intellectual Property Institute of Canada (IPIC) and the International Association for the Protection of Intellectual Property (AIPPI Standing Committee on Biotechnology). Jason is a Fellow of the Litigation Counsel of America, a member of the Advocates’ Society, and a member of the Canadian Bar Association (CBA).

Reported Decisions

Supreme Court of Canada

Federal Court of Appeal

Federal Court

Ontario Superior Court of Justice

Patented Medicine Prices Review Board

In the matter of Alexion Pharmaceuticals Inc. (Respondent) and the medicine Soliris, Board Order dated June 21, 2022